Open Access
Cecil tratado de medicina interna
J. Claude Bennett,Fred Plum +1 more
- 01 Jan 1997
pp 1297-1297
620
About: The article was published on 01 Jan 1997. and is currently open access.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Perfil dos betas bloqueadores atenolol e enalapril dispensados em farmácia magistral da cidade de pelotas, rio grande do sul
Rafael da Fonseca Prietsch
- 30 Sep 2013
TL;DR: O objetivo deste estudo, quantitativo, descritivo e retrospectivo, nos meses de 01/05/11 e 01/10/11 foi avaliar segundo a sua classe farmacologica, observar qual destes medicamentos anti-hipertensivos possui uma maior prevalencia na utilizacao.
Determinación de aspectos morfológicos y hemodinámicos en las arterias de los miembros pélvicos en insuficiencia arterial
Karla Bertha Sánchez Vargas,Francisco Ayala González,Carlos Ramón Ocampo López,Ricardo Balcazar Vázquez +3 more
- 01 Jan 2007
TL;DR: In the group of cases the presence of morphological and hemodynamic changes as expected secondary to the original pathology was corroborated, and the origin may be explained as secondary to endothelial dysfunction that could develop structural changes that lead to atherosclerosis.
Manifestação incomum do câncer colorretal: relato de caso
Cláudio Ferreira Mendonça,Augusto Diogo Filho,Diogo Almeida Lima,Luciano Batista Silveira Santos,Carla Corrêa Lima Dias +4 more
TL;DR: An uncommon manifestation of this type of neoplasm that showed up with an unusual complication in the moment of the diagnosis of a colorectal adenocarcinoma is reported.
Prevalence of factor V Leiden in patients with venous thrombosis Prevalência do fator V de Leiden em pacientes com trombose venosa
Cristiane Aparecida Michel,Julia B. Rocha,Daiane C. Costa,Carlos Augusto Lima,Anna Paula,B. Batschauer +5 more
- 01 Jan 2016
TL;DR: The research of mutation on factor V has strong impact on investigation of venous thromboembolism, in order to elucidate the etiology of the event, and in treatment and in prophylaxis against the recurrence.
1